Th2 and Th17 CD4 T cells are not always considered a positive feature of tumor environments45,46; however, patients with tumors expressing increased proportions of ICOS-expressing CD4 T cells have an improved prognosis31. The gene discussed is CD4; the disease is neoplasm.